ANKE BRAUEL,DIRK EVERS,FRITJOF EVERS,SABINE FIELHAUER,DR. HENNING,RICARDA MEYER,IVANA STRAHINJIC,KLAUS TREUDLER,MARLIES VOLLUS
申请号：
PT07014491
公开号：
PT1886686E
申请日:
2007.07.24
申请国别(地区):
PT
年份:
2013
代理人:
摘要：
Pharmaceutical composition for the application on skin, comprises (in wt.%): mometasone furoate (0.01-0.2)； water (10-90)； a combination of at least an aromatic alcohol and at least a solvent from a first group containing alkoxylated 8-22C-fatty-alcohol, alkoxylated- or non-alkoxylated 8-22C-fatty acid, and alkoxylated- or non-alkoxylated carboxylic acid ester of 8-22C-carboxylic acid, and/or a second group containing 2-10C-polyvalent aliphatic alcohol, polyalkylene glycol of 2-4C-alkylene and a non-alkoxylated ether； and optionally further additives. Pharmaceutical composition (I) for the application on skin, comprises (in wt.%): mometasone furoate (0.01-0.2)； water (10-90)； a combination of at least an aromatic alcohol and at least a solvent from a first group containing alkoxylated 8-22C-fatty-alcohol, alkoxylated- or non-alkoxylated 8-22C-fatty acid, and alkoxylated- or non-alkoxylated carboxylic acid ester of 8-22C-carboxylic acid, and/or a second group of 2-10C-polyvalent aliphatic alcohol, polyalkylene glycol of 2-4C-alkylene, and non-alkoxylated ether of the polyvalent aliphatic alcohol and polyalkylene glycol with a further component of 1-4C-ether； and optionally further additives. ACTIVITY : Antiinflammatory； Dermatological； Antipsoriatic. MECHANISM OF ACTION : None given.
